Drug intelligence / Profile preview

Reconval B6

Development stage: Unknown
Lead developer: Pharmadab
Modality: Small Molecules
Administration: Topical

Overview

**Reconval B6** is a Pharmadab topical supportive skin-care cream formulated with vitamin B6, urea, and allantoin for skin affected by cancer treatment. It is marketed for preventive and supportive care of radiodermatitis and chemotherapy- or targeted-therapy-associated hand-foot syndrome, helping moisturize dry, cracked, peeling, and irritated skin. The product is intended for topical application to affected areas, including prophylactic use on the hands and feet beginning with cancer treatment; its precise pharmacologic mechanism has not been established.

Brand names: Reconval B6

Beyond the preview

Go deeper on Reconval B6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reconval B6.

Explore the full profile